Open Access

Mechanisms of cancer-related cardiomyopathy

Event: Frontiers in CardioVascular Biology 2016
Topic: Myocardium
Session type: Featured Symposium
Date: 8 July 2016
Time: 17:00 - 18:30


6 presentations in this session

Sexual dimorphism of anthracycline cardiotoxicity

Speaker: Associate Professor M. Moulin (Chatenay-Malabry, FR)

AKAP signalling in chemotherapy-induced heart disease.

Speaker: Associate Professor D. Diviani (Lausanne, CH)

Targeting PI3Kgamma in cancer therapy: how to kill two birds with one stone.

Speaker: Associate Professor A. Ghigo (Turin, IT)

Protection against chemotherapy cardiotoxicity by the human amniotic fluid stem cell secretome: a new tool for future paracrine therapy.

Speaker: Assistant Professor S. Bollini (Genova, IT)

Hyperlipidaemia reduces mortality in breast, prostate, lung and bowel cancer

Speaker: Doctor P. Carter (London, GB)

DNA-repair in cardiomyocytes is critical for maintaining cardiac function

Speaker: Miss M. De Boer (Rotterdam, NL)

6 speakers from this session

Associate Professor Maryline Moulin

Inserm UMR-S 769, LabEx LERMIT, University Paris-Sud, Chatenay-Malabry (France)
1 presentation
0 follower

Associate Professor Dario Diviani

, Lausanne (Switzerland)
1 presentation
0 follower

Associate Professor Alessandra Ghigo

University of Turin - Molecular Biotechnology Center, Turin (Italy)
4 presentations
0 follower

Assistant Professor Sveva Bollini

University of Genova, Genova (Italy)
0 follower

Doctor Paul Richard Carter

University of Cambridge, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Miss Martine De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
0 follower

This platform is supported by

logo Novo Nordisk